Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
In humans, solute carrier family 22 member 10 pseudogene (SLC22A10P, ENSG00000256181) is a unitary pseudogene within the SLC22 organic ion transporter family. Unlike functional members of the SLC22 family, human SLC22A10P is inactivated due to a fixed missense mutation (Pro220), which disrupts its protein coding potential and prevents plasma membrane localization and transport activity. While orthologs in great apes and other primates function as steroid glucuronide transporters (notably for estradiol-17β-glucuronide), the human version does not produce a functional transporter, meaning it lacks canonical biological function and clinical relevance. Its evolutionary inactivation may have contributed to changes in steroid metabolism unique to humans, but it is not currently relevant for therapeutic targeting, drug development, or biomarker use[1][2]. If structured data extraction is required for bioinformatics or target annotation, this entry should be handled as a non-functional pseudogene and excluded from lists of valid therapeutic targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 22 member 10 pseudogene (SLC22A10P).